v3.25.4
ACQUISITIONS, DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS - Schedule of Consideration for RayzeBio Acquisition (Details) - RayzeBio - USD ($)
$ in Millions
12 Months Ended
Feb. 26, 2024
Dec. 31, 2024
Business Combination [Line Items]    
Acquisitions (Note 4) $ 4,147  
Total consideration allocated 3,873  
Common Stock    
Business Combination [Line Items]    
Acquisitions (Note 4) 3,851  
Equity    
Business Combination [Line Items]    
Acquisitions (Note 4) 296  
Unvested Equity Awards    
Business Combination [Line Items]    
Acquisitions (Note 4) $ 274  
Unvested Equity Awards | Selling, general and administrative    
Business Combination [Line Items]    
Acquisitions (Note 4)   $ 159
Unvested Equity Awards | Research and development    
Business Combination [Line Items]    
Acquisitions (Note 4)   $ 115